ARMF009P-25C
                    [Monoclonal Antibody]
              
                
                    Phospho-MAPK1/3-Thr202/Tyr204 Rabbit Monoclonal Antibody (Magnetic Bead Conjugate)
                	
                
             
            
            	
                
www.yhsbio.com
market@yhsbio.com
support@yhsbio.com
+86-21-54651191
Room 703,Building 6,333# Guiping
Rd.,Xuhui District,Shanghai,China
                
             
         
        
        	
           	  DATASHEET
                
                	
                    	
                        	| Species: | Rabbit | 
                        
                        	| Applications: | IP | 
                        
                        	| Immunogen Range: | A synthetic phosphopeptide corresponding to residues surrounding Thr202/Tyr204 of human p44 MAP kinase | 
                        
                        	| Clonality: | Monoclonal Antibody | 
                        
                        	| Isotype: | IgG | 
                        
                        	| GENE ID: | 5594/5595 | 
                        
                        	| Swiss Prot: | P27361/P28482 | 
                        
                        	| Synonyms: | / | 
                        
                        	| Purification: | Affinity purification | 
                        
                        	| Storage: | Store at -20°C in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Avoid freeze/thaw cycles. | 
                        
                        	| Background: | Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs, such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines (1-3), and research investigators consider it an important target in the diagnosis and treatment of cancer (4). Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/COT. MEK1 and MEK2 are the primary MAPKKs in this pathway (5,6). MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK (7) and the transcription factor Elk-1 (8,9). p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs (10), along with MEK inhibitors, such as U0126 and PD98059. | 
                    
                 
             
            
            	
                	
                    	
                        	| Caculated MW: | 42, 44 kDa | 
                        
                        	| Observed MW: | Refer to Figures | 
                        
                        	| Applications: |  | 
                        
                        	| Reacitivity: | Bovine, D. melanogaster, Dog, Hamster, Human, Monkey, Mouse, Pig, Rat, S. cerevisiae, Zebrafish | 
                    
                 
                
                	For research use only. Not intended for diagnostic or therapeutic use!